Skip to main content
Erschienen in:

07.12.2018 | Original Article

Distribution of lymphomas in Mexico: a multicenter descriptive study

verfasst von: Adrian Carballo-Zarate, Alejandro Garcia-Horton, Lizbeth Palma-Berre, Patricia Ramos-Salazar, Rogelio Sanchez-Verin-Lucio, Jorge Valenzuela-Tamariz, Lourdes Molinar-Horcasitas, Alejandro Lazo-Langner, Alejandra Zarate-Osorno

Erschienen in: Journal of Hematopathology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Epidemiology of lymphoma is not well described in Mexico. We determined the frequencies and subtypes of the main non-Hodgkin’s and Hodgkin’s lymphomas in the Mexican population. Files for tissue samples for lymphomas stored in five different hospitals in Mexico City were retrieved for re-analysis and further immunostaining. The most common mature B cell, T cell/NK cell, Hodgkin’s, and precursor lymphoid neoplasms were identified according to the 2008 WHO classification of tumors. All stains were performed in the same laboratory and interpreted by three pathologists. Five thousand seven hundred seventy-two neoplasms were included. Of these, 4213 were mature B cell neoplasms (73%; 95% CI 71.83–74.12), 888 Hodgkin’s lymphomas (HLs) (15%; 95% CI 14.48–16.34), 496 mature T cell/NK neoplasms (9%; 95% CI 7.89–9.34), and 175 precursor lymphoid neoplasms (3%; 95% CI 2.62–3.5). Neoplasms had an even distribution between sexes. Main mature B cell lymphomas were diffuse large B cell lymphoma (DLBCL) (56%; 95% CI 54.39–57.39) and follicular lymphoma (FL) (20%; 95% CI 18.92–21.34). Hodgkin’s lymphomas were also classified into five main subtypes, with nodular sclerosis (47%; 95% CI 44.14–50.7) and mixed cellularity (38%; 95% CI 34.49–40.85) being the most common. The most common mature T cell/NK neoplasm was peripheral T cell lymphoma NOS/anaplastic large cell lymphoma ALK negative (44%; 95% CI 39.85–48.84). This is the first descriptive study in Mexico with a large sample of lymphomas classified according to the 2008 WHO classification. The results obtained are in keeping with the numbers described in other populations.
Literatur
3.
Zurück zum Zitat Meneses-García A, Ruiz-Godoy LM, Beltrán-Ortega A, Sánchez-Cervantes F, Tapia-Conyer R, Mohar A (2012) Main malignant neoplasms in Mexico and their geographic distribution, 1993-2002. Rev Investig Clin 64(4):322–329 Meneses-García A, Ruiz-Godoy LM, Beltrán-Ortega A, Sánchez-Cervantes F, Tapia-Conyer R, Mohar A (2012) Main malignant neoplasms in Mexico and their geographic distribution, 1993-2002. Rev Investig Clin 64(4):322–329
4.
Zurück zum Zitat Benitez-Aranda H (2002) Epidemiologia de las enfermedades hematologicas en el ambito nacional. Gac Med Mex 138(2):S12–SS8 Benitez-Aranda H (2002) Epidemiologia de las enfermedades hematologicas en el ambito nacional. Gac Med Mex 138(2):S12–SS8
5.
Zurück zum Zitat Soto-Estrada G, Moreno-Altamirano L, Palma-Diaz D (2016) Panorama epidemiologico de Mexico, principales causas de morbilidad y mortalidad. Rev Fac Med UNAM 59(6):8–22 Soto-Estrada G, Moreno-Altamirano L, Palma-Diaz D (2016) Panorama epidemiologico de Mexico, principales causas de morbilidad y mortalidad. Rev Fac Med UNAM 59(6):8–22
7.
Zurück zum Zitat Swerdlow SH, World Health Organization, International Agency for Research on Cancer (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon 585 pages Swerdlow SH, World Health Organization, International Agency for Research on Cancer (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon 585 pages
8.
Zurück zum Zitat Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon 439 p Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon 439 p
9.
Zurück zum Zitat Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjose S, Smedby KE, Chiu BCH, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadie M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, la Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014(48):130–144CrossRefPubMedPubMedCentral Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjose S, Smedby KE, Chiu BCH, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadie M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, la Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014(48):130–144CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mendoza-Sanchez HF, Quintana-Sanchez JA, Rivera-Marquez H, Mejia-Dominguez AM, Fajardo-Gutierrez A (1998) Epidemiology of lymphomas in children residing in Mexico City. Arch Med Res 29(1):67–73PubMed Mendoza-Sanchez HF, Quintana-Sanchez JA, Rivera-Marquez H, Mejia-Dominguez AM, Fajardo-Gutierrez A (1998) Epidemiology of lymphomas in children residing in Mexico City. Arch Med Res 29(1):67–73PubMed
12.
Zurück zum Zitat Ortega V, Verastegui E, Flores G, Meneses A, Ocadiz R, Alfaro G (1998) Non-Hodgkin’s lymphomas in Mexico. A clinicopathological and molecular analysis. Leuk Lymphoma 31(5–6):575–582CrossRefPubMed Ortega V, Verastegui E, Flores G, Meneses A, Ocadiz R, Alfaro G (1998) Non-Hodgkin’s lymphomas in Mexico. A clinicopathological and molecular analysis. Leuk Lymphoma 31(5–6):575–582CrossRefPubMed
13.
Zurück zum Zitat Rendon-Macias ME, Valencia-Ramon EA, Fajardo-Gutierrez A, Rivera-Flores E (2015) Childhood lymphoma incidence patterns by ICCC-3 subtype in Mexico City metropolitan area population insured by Instituto Mexicano del Seguro Social, 1996-2010. Cancer Causes Control 26(6):849–857CrossRefPubMed Rendon-Macias ME, Valencia-Ramon EA, Fajardo-Gutierrez A, Rivera-Flores E (2015) Childhood lymphoma incidence patterns by ICCC-3 subtype in Mexico City metropolitan area population insured by Instituto Mexicano del Seguro Social, 1996-2010. Cancer Causes Control 26(6):849–857CrossRefPubMed
14.
Zurück zum Zitat Ron-Guerrero CR-MA, Medina-Palacios CL, Lopez-Flores F (2015) Epidemiologia de los linfomas del Centro Estatal de Cancerologia de Nayarit. Rev Hematol Mex 16:109–114 Ron-Guerrero CR-MA, Medina-Palacios CL, Lopez-Flores F (2015) Epidemiologia de los linfomas del Centro Estatal de Cancerologia de Nayarit. Rev Hematol Mex 16:109–114
15.
Zurück zum Zitat Rivera-Luna R, Shalkow-Klincovstein J, Velasco-Hidalgo L, Cardenas-Cardos R, Zapata-Tarres M, Olaya-Vargas A et al (2014) Descriptive epidemiology in Mexican children with cancer under an open national public health insurance program. BMC Cancer 14:790CrossRefPubMedPubMedCentral Rivera-Luna R, Shalkow-Klincovstein J, Velasco-Hidalgo L, Cardenas-Cardos R, Zapata-Tarres M, Olaya-Vargas A et al (2014) Descriptive epidemiology in Mexican children with cancer under an open national public health insurance program. BMC Cancer 14:790CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17(8):857–872CrossRefPubMed Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17(8):857–872CrossRefPubMed
17.
Zurück zum Zitat Ambinder AJ, Shenoy PJ, Malik N, Maggioncalda A, Nastoupil LJ, Flowers CR (2012) Exploring risk factors for follicular lymphoma. Adv Hematol 2012:626–635CrossRef Ambinder AJ, Shenoy PJ, Malik N, Maggioncalda A, Nastoupil LJ, Flowers CR (2012) Exploring risk factors for follicular lymphoma. Adv Hematol 2012:626–635CrossRef
18.
Zurück zum Zitat Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534CrossRefPubMed Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534CrossRefPubMed
20.
Zurück zum Zitat Laurini JA, Perry AM, Boilesen E, Diebold J, Maclennan KA, Muller-Hermelink HK et al (2012) Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. Blood 120(24):4795–4801CrossRefPubMed Laurini JA, Perry AM, Boilesen E, Diebold J, Maclennan KA, Muller-Hermelink HK et al (2012) Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. Blood 120(24):4795–4801CrossRefPubMed
23.
Zurück zum Zitat Tirado-Gómez L, Mohar-Betancourt A (2007) Epidemiología de las Neoplasias Hemato-Oncológicas. Cancerología 2:109–120 Tirado-Gómez L, Mohar-Betancourt A (2007) Epidemiología de las Neoplasias Hemato-Oncológicas. Cancerología 2:109–120
24.
Zurück zum Zitat Smith A, Crouch S, Howell D, Burton C, Patmore R, Roman E (2015) Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiol 39(6):1103–1112CrossRefPubMedPubMedCentral Smith A, Crouch S, Howell D, Burton C, Patmore R, Roman E (2015) Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiol 39(6):1103–1112CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Tadmor T, Shvidel L, Bairey O, Goldschmidt N, Ruchlemer R, Fineman R, Rahimi-Levene N, Herishanu Y, Yuklea M, Arad A, Aviv A, Polliack A, On behalf of the Israeli CLL Study Group (2014) Richter’s transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group. Am J Hematol 89(11):E218–E222CrossRefPubMed Tadmor T, Shvidel L, Bairey O, Goldschmidt N, Ruchlemer R, Fineman R, Rahimi-Levene N, Herishanu Y, Yuklea M, Arad A, Aviv A, Polliack A, On behalf of the Israeli CLL Study Group (2014) Richter’s transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group. Am J Hematol 89(11):E218–E222CrossRefPubMed
27.
Zurück zum Zitat Warnke RA, Jones D, Hsi ED (2007) Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics. Am J Clin Pathol 127(4):511–527CrossRefPubMed Warnke RA, Jones D, Hsi ED (2007) Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics. Am J Clin Pathol 127(4):511–527CrossRefPubMed
28.
Zurück zum Zitat Perry AM, Diebold J, Nathwani BN, MacLennan KA, Muller-Hermelink HK, Bast M et al (2016) Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project. Ann Hematol 95(2):245–251CrossRefPubMed Perry AM, Diebold J, Nathwani BN, MacLennan KA, Muller-Hermelink HK, Bast M et al (2016) Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project. Ann Hematol 95(2):245–251CrossRefPubMed
29.
Zurück zum Zitat Yamaguchi K, Takatsuki K (1993) Adult T cell leukaemia-lymphoma. Baillieres Clin Haematol 6(4):899–915CrossRefPubMed Yamaguchi K, Takatsuki K (1993) Adult T cell leukaemia-lymphoma. Baillieres Clin Haematol 6(4):899–915CrossRefPubMed
30.
Zurück zum Zitat Jhuang JY, Chang ST, Weng SF, Pan ST, Chu PY, Hsieh PP, Wei CH, Chou SC, Koo CL, Chen CJ, Hsu JD, Chuang SS (2015) Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors. Hum Pathol 46(2):313–321CrossRefPubMed Jhuang JY, Chang ST, Weng SF, Pan ST, Chu PY, Hsieh PP, Wei CH, Chou SC, Koo CL, Chen CJ, Hsu JD, Chuang SS (2015) Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors. Hum Pathol 46(2):313–321CrossRefPubMed
31.
Zurück zum Zitat Cabrera ME, Martinez V, Nathwani BN, Muller-Hermelink HK, Diebold J, Maclennan KA et al (2012) Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists. Leuk Lymphoma 53(7):1311–1317CrossRefPubMed Cabrera ME, Martinez V, Nathwani BN, Muller-Hermelink HK, Diebold J, Maclennan KA et al (2012) Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists. Leuk Lymphoma 53(7):1311–1317CrossRefPubMed
32.
Zurück zum Zitat Laurent C, Do C, Gourraud PA, de Paiva GR, Valmary S, Brousset P (2015) Prevalence of common non-Hodgkin lymphomas and subtypes of Hodgkin lymphoma by nodal site of involvement: a systematic retrospective review of 938 cases. Medicine (Baltimore) 94(25):e987CrossRef Laurent C, Do C, Gourraud PA, de Paiva GR, Valmary S, Brousset P (2015) Prevalence of common non-Hodgkin lymphomas and subtypes of Hodgkin lymphoma by nodal site of involvement: a systematic retrospective review of 938 cases. Medicine (Baltimore) 94(25):e987CrossRef
33.
Zurück zum Zitat Salati M, Cesaretti M, Macchia M, Mistiri ME, Federico M (2014) Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin. Mediterr J Hematol Infect Dis 6(1):2014048CrossRef Salati M, Cesaretti M, Macchia M, Mistiri ME, Federico M (2014) Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin. Mediterr J Hematol Infect Dis 6(1):2014048CrossRef
34.
Zurück zum Zitat Thomas RK, Re D, Zander T, Wolf J, Diehl V (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol 13(Suppl 4):147–152CrossRefPubMed Thomas RK, Re D, Zander T, Wolf J, Diehl V (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol 13(Suppl 4):147–152CrossRefPubMed
36.
Zurück zum Zitat Moreno-Estrada A, Gignoux CR, Fernandez-Lopez JC, Zakharia F, Sikora M, Contreras AV, Acuna-Alonzo V, Sandoval K, Eng C, Romero-Hidalgo S, Ortiz-Tello P, Robles V, Kenny EE, Nuno-Arana I, Barquera-Lozano R, Macin-Perez G, Granados-Arriola J, Huntsman S, Galanter JM, Via M, Ford JG, Chapela R, Rodriguez-Cintron W, Rodriguez-Santana JR, Romieu I, Sienra-Monge JJ, Navarro BR, London SJ, Ruiz-Linares A, Garcia-Herrera R, Estrada K, Hidalgo-Miranda A, Jimenez-Sanchez G, Carnevale A, Soberon X, Canizales-Quinteros S, Rangel-Villalobos H, Silva-Zolezzi I, Burchard EG, Bustamante CD (2014) Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science 344(6189):1280–1285CrossRefPubMedPubMedCentral Moreno-Estrada A, Gignoux CR, Fernandez-Lopez JC, Zakharia F, Sikora M, Contreras AV, Acuna-Alonzo V, Sandoval K, Eng C, Romero-Hidalgo S, Ortiz-Tello P, Robles V, Kenny EE, Nuno-Arana I, Barquera-Lozano R, Macin-Perez G, Granados-Arriola J, Huntsman S, Galanter JM, Via M, Ford JG, Chapela R, Rodriguez-Cintron W, Rodriguez-Santana JR, Romieu I, Sienra-Monge JJ, Navarro BR, London SJ, Ruiz-Linares A, Garcia-Herrera R, Estrada K, Hidalgo-Miranda A, Jimenez-Sanchez G, Carnevale A, Soberon X, Canizales-Quinteros S, Rangel-Villalobos H, Silva-Zolezzi I, Burchard EG, Bustamante CD (2014) Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science 344(6189):1280–1285CrossRefPubMedPubMedCentral
Metadaten
Titel
Distribution of lymphomas in Mexico: a multicenter descriptive study
verfasst von
Adrian Carballo-Zarate
Alejandro Garcia-Horton
Lizbeth Palma-Berre
Patricia Ramos-Salazar
Rogelio Sanchez-Verin-Lucio
Jorge Valenzuela-Tamariz
Lourdes Molinar-Horcasitas
Alejandro Lazo-Langner
Alejandra Zarate-Osorno
Publikationsdatum
07.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Hematopathology / Ausgabe 4/2018
Print ISSN: 1868-9256
Elektronische ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-018-0336-0

Neu im Fachgebiet Pathologie

Overview of a comparative analysis of microsatellite instability and standard mismatch repair protein-deficiency tests in a large cancer cohort

  • Hauptreferate: Hauptprogramm der DGP

A retrospective analysis was carried out based on a large cancer patient cohort of our institute ( n  = 1306; collected from 2018 to 2023). dMMR was tested by four IHC reactions (MLH1 and PMS2 or MSH2 and MSH 6). Further, parallel pentaplex …

Molekulare Testung bei mesenchymalen Neoplasien: Was, wann und wie testen?

Mit dem weit verbreiteten Einsatz diverser molekularer Methoden in der histopathologischen Routinediagnostik hat die Tumorklassifikation in den letzten beiden Jahrzehnten signifikante Fortschritte gemacht. Dabei wurden zum einen zahlreiche …

Reconstructing 3D histological structures using machine learning (artificial intelligence) algorithms

  • Hauptreferate: Hauptprogramm der DGP

Artificial intelligence (AI) has recently been applied to pathological and medical image analysis with high sensitivity and specificity [ 1 , 2 ], aiding in various dental diagnostic techniques. The use of AI in image annotation has enhanced the …

Key considerations when implementing new diagnostic technologies in routine practice

  • Hauptreferate: Arbeitsgemeinschaften der DGP

This review explores several key considerations that are critical for implementing new diagnostic technologies into routine practice. These elements will provide a comprehensive guide for navigating the complexities of integrating cutting-edge …